ASH 2024 Summary: Highlights in Bone Marrow Failure Disorders

2024 ASH Annual Meeting Insights Hub

P. Scheinberg

Thalassemia: Overview of Pathophysiology and Risk for Malignancies

Ali Taher

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

Updates in Thrombosis and Anticoagulation

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

D. Garcia

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Integrity CE

A. Tefferi

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Current Treatment Guidelines for ITP: Individualized Therapy and Eme…

Irina Murakhovskaya

Is There a Role for Splenectomy in ITP?

Platelet Disorder Support Association (PDSA)

C. Kessler

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

Switching ITP Patients to Avatrombopag From Other TPO-RAs: When to D…

Keck School of Medicine of USC

H. Liebman

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz

Natural History of ITP: Navigating the Journey

Platelet Disorder Support Association (PDSA)

D. Kuter

Are All New ITP Treatments Better Than Old Ones: Other Treatments to…

Platelet Disorder Support Association (PDSA)

H. Liebman

Management of iTTP

Yazan Abou-Ismail

Evolving Treatment Landscape in ITP

Robert Bird

Management of Treatment-Naive ITP Patients

Weill Cornell Medicine Oncology & Hematology

J. Bussel

ITP: Diagnosis, Pathophysiology, and Management Guidelines

Songphol Tungjitviboonkun